Chugai victorious in patent royalties dispute at English High Court

28-08-2018

Chugai victorious in patent royalties dispute at English High Court

Artur / iStockphoto.com

Late last week, Chugai Pharmaceutical emerged victorious after the English High Court found that the Japan-based company doesn’t owe royalties under a patent licence with UCB.


English High Court, UCB Pharma, Chugai, patent, Celltech, licence, royalties, antibodies, tocilizumab

LSIPR